Our current model proposes that EP3 and EP4 play opposing roles in the heart and that shifting the balance toward increased EP4 activity will be beneficial in the setting of diabetic cardiomyopathy. The gene discussed is PTGER3; the disease is diabetic cardiomyopathy.